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Arterial stiﬀness is increased in type 1 diabetes (T1D), before any clinical complications of the disease are evident. The aim of the
present paper was to investigate the association between cardiac autonomic function and arterial stiﬀness in a cohort of young
T1D patients, without history of hypertension and any evidence of macrovascular and/or renal disease. Large artery stiﬀness
was assessed by measurement of carotid-femoral pulse wave velocity (PWV). Cardiac autonomic function was assessed by the
cardiovasculartestsproposedbyEwingandClarke.Patientswithahighcardiacautonomicneuropathyscore(≥4)hadsigniﬁcantly
higher PWV than those with a low score (0-1). A negative, heart rate-independent, correlation between PWV and heart rate
variation during respiration was observed (r =− 0.533, P<0.001). In multivariable analysis, E/I index was the strongest correlate
of PWV (β-coeﬃcient = −0.326, P = 0.002). Cardiac parasympathetic function is a strong predictor of large arterial stiﬀness, in
young T1D patients free of macrovascular and renal complications.
1.Introduction
Arterial stiﬀness increases as a result of the aging process
and as a consequence of many disease states, including
diabetes mellitus (DM) [1–6]. Aortic stiﬀness has indepen-
dent predictive value for total and cardiovascular mortality,
coronarymorbidityandmortality,andfatalstrokeinvarious
populations at high risk for cardiovascular disease [4–6].
Vascular compliance of both the large and small arteries is
reduced in patients with type 1 diabetes (T1D), at an early
stage of the disease and before any clinical macrovascular or
microvascular complications are evident, therefore increas-
ing their risk for cardiovascular events [7–9]. The early
presence of increased arterial stiﬀness in patients with T1D
is believed to be a consequence of the blood vessels exposure
to the chronic detrimental eﬀects of hyperglycemia [10–12].
Diabeticautonomicneuropathy(DAN)isaserious,often
overlooked, complication of DM. Cardiovascular autonomic
neuropathy (CAN) is the most studied form of DAN and its
prevalence varies dramatically between cohorts of diabetic
patients, due to diﬀerences in the methodology used for its
diagnosis and the lack of method standardization [13–15].
It has been reported that subclinical autonomic dysfunction
may occur within two years of the diagnosis in patients
with T1D [16]. Reduced cardiovascular autonomic function
has been associated with increased total mortality and
cardiovascular morbidity as well as mortality [17, 18].
Few previous studies have explored the hypothesis
that early impairment of the cardiovascular structure and
function and early abnormalities of the autonomic nervous
system in patients with T1D might be interrelated, and have
shownconﬂictingresults[19–22].Althoughtheseabnormal-
ities could also be separate and unrelated (despite occurring
in parallel time periods) consequences of the diabetic
hyperglycemic environment, they might also be reversible.
In view of these considerations, the aim of the present
study was to investigate whether there is an association
between cardiac autonomic function and large artery com-
pliance in a cohort of patients with T1D, without hyperten-
sion and/or any clinical evidence of macrovascular or renal
disease.
2. Patients andMethods
Patients with T1D were consecutively selected from the out-
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that patients were under 40 years of age, with an HbA1c <
8%, and had no history of arterial hypertension, macrovas-
cular disease, or renal disease, including microalbuminuria.
Patients receiving statins were excluded from the study.
Since the performance of reliable cardiovascular autonomic
tests requires the exclusion of potential confounding factors,
such us concomitant illnesses and drug use (b-blockers,
other antiarrhythmic drugs, antidepressants, antihistamines,
and diuretics) those have been carefully ruled out [23].
In addition, patients were advised to refrain from certain
potentially confounding lifestyle activities (exercise, smok-
ing, and caﬀeine intake), and not to eat in the morning of the
examination. All participants were given explanations about
the purpose and the procedures of the study and then signed
an informed consent. The study was approved by the ethics
committee of the Laiko University Hospital.
Arterial stiﬀness was assessed noninvasively using the
estimation of pulse wave velocity (PWV) which has emerged
as the “gold-standard” for the measurement of regional arte-
rial stiﬀness [24]. The theoretical basis of PWV is described
by the Moens-Korteweg equation: PWV2 = E∗h/2rρ;w h e r e
E is the slope of stress-strain relationship for a given vessel,
Young’s modulus; ρ is the density of ﬂuid; h/2r is the wall
thickness/diameter. PWV was calculated by measuring the
timetakenforthearterialpulsetopropagatefromthecarotid
to the femoral artery. The SphygmoCor system was used
[25], which involves an arterial tonometer for recording
pressure waveforms. Propagation time is measured from the
foot of the carotid waveform to that of the femoral waveform
using sequential recordings referenced to ﬁxed points of the
cardiac cycle (the R wave of the electrocardiogram).
Cardiac autonomic function was assessed using the
battery of cardiovascular tests, proposed by Ewing et al. [26]
and recommended by the American Diabetes Association’s
(ADA) consensus statement on standardized measures in
diabetic [23]. Heart rate response during respiration (the
deep breathing test) was assessed by calculating the ratio of
the maximum and minimum heart rates during six cycles
of paced deep breathing (E/I index). Heart rate response to
standing (standing test) was calculated as the ratio of the
longest R-R interval (found at about beat 30) to the shortest
R-R interval (found at about beat 15) after standing up
(30:15 ratio). Heart rate response to the Valsalva maneuver
(Valsalva test) was assessed by calculating the ratio of the
longest R-R interval after the maneuver to the shortest R-R
intervalduringorshortlyafterthemaneuver(VMindex).All
calculations were undertaken by measuring ECG recordings
of RR intervals automatically, using the computer-aided
examination and evaluation system VariaCardio TF4 (Medi-
cal Research Limited, Leeds, UK) [27].
The heart rate-based tests were evaluated according to
published age-related tables [28]. Orthostatic hypotension
was diagnosed when a fall in systolic blood pressure
>20mmHg was observed; a fall of 11–20mmHg was con-
sidered as borderline and a fall of <10mmHg as normal
response. Each normal autonomic function test was graded
as 0.0, each borderline test as 1.0 and each abnormal test as
2.0. On the basis of the sum of this score, the total CAN score
was calculated as the sum of the partial scores (minimum: 0,
Table 1: Demographic and clinical characteristics of the study
population.
N (%)/mean (SD)
Gender (males/females) 31 (47)/35 (53)
Age (years) 27.1 (6.0)
BMI (kg/m2) 24.2 (3.1)
Diabetes duration (years) 12.3 (7.7)
Current smoking 23 (35)
HbA1c (%) 7.4 (4.5)
Type of insulin treatment (MDI/CSII) 55 (83.3)/11 (16.7)
SBP (mmHg) 120.9 (13.1)
DBP (mmHg) 78.5 (12.5)
LDL-C (mg/dL) 99.8 (23.5)
HDL-C (mg/dL) 60.8 (13.4)
Triglycerides (mg/dL) 63.2 (32.1)
SBP: systolic blood pressure, DBP: diastolic blood pressure, MDI: multiple
daily injections, CSII: continuous, subcutaneous insulin infusion.
maximum: 8). CAN was diagnosed when two out of the four
tests performed were abnormal [23].
All tests were carried out between 07:00 and 09:00h, in
a quiet environment with stable temperature (22–24◦C). All
PWV and CAN measurements were assessed by the same
person.
Statistical analysis was performed using the statistical
package SPSS 15.0.1 (SPSS Inc., Chicago, IL, USA). All data
were assessed for normal distribution of the values. Cat-
egorical data were compared using a Chi-square test. Com-
parisons of normally distributed data, between groups, were
performed by the independent samples Student’s t-test or by
ANOVA.SimplecorrelationswereperformedusingPearson’s
or Spearman’s correlation coeﬃcient, as appropriate. Multi-
variable stepwise linear regression analysis was used to assess
theindependentcontributionofvariablespossiblyassociated
with PWV. P values (two-tailed) < 0.05 were considered
statistically signiﬁcant.
3. Results and Discussion
A total of 66 patients were included in the study, out
of whom 31 (46.97%) were men. The mean age was
27.1 years while the mean duration of diabetes was 12.3
years. All patients were under intensive insulin treatment
(basal-bolusregimens)and11(16.66%)receivedcontinuous
subcutaneous insulin infusion via an insulin pump. The
patients had decent glycemic control (mean HbA1c: 7.4%).
The demographic and clinical characteristics of the study
participants are shown in detail in Table 1. Seven patients
fulﬁlled the criteria of CAN diagnosis (score ≥ 4). Only
four patients had an abnormal Valsalva test while 17 had
an abnormal deep breathing test. Data for Valsalva index
are missing for ﬁve patients due to poor compliance in
performingthetest.ThemeanvaluesofPWVandtheindices
of cardiac autonomic function are shown in Table 2.
Patients with a high total CAN score (≥4) had a
signiﬁcantly higher PWV value than those with a lowExperimental Diabetes Research 3
Table 2: Pulse wave velocity and indices of autonomic function in
the study population.
N (%)/mean (SD)
Pulse wave velocity (m/s) 5.6 (0.9)
E/I index 1.33 (0.16)
E/I index (normal/borderline/low) 39/10/17
(59.1/15.2/25.7)
30:15 index 1.33 (0.18)
30:15 index (normal/borderline/low) 51/5/10 (77.3/7.6/15.1)
Valsalva index 1.94 (0.40)
Valsalva index∗ (normal/borderline/low) 50/7/4 (75.8/10.6/6.1)
Change in SBP (mmhg) −0.36 (9.84)
Change in SBP (normal/borderline/low) 58/5/3 (87.8/7.6/4.6)
Total score (median) 1.0 (0.0–7.0)
Presence of CAN (yes/no) 7/59 (10.6/89.4)
∗Not available in 5 patients due to poor compliance in performing the test.
total score (0-1; Table 3). PWV was signiﬁcantly higher
in patients with abnormal deep breathing and standing-
up tests, compared to patients with normal result tests
w h i l et h e r ew a sn os u c hd i ﬀerence observed regarding the
Valsalva maneuver test and the orthostatic blood pressure
test (Table 3). After adjustment for age, gender and duration
of diabetes, the diﬀerence in PWV between patients with
normal and abnormal tests remained signiﬁcant only for the
deep breathing test (P = 0.012) while borderline signiﬁcance
was observed regarding patients with high versus low total
CAN score (P = 0.067).
In univariate analysis, PWV correlated positively with
age (r = 0.527, P<0.001), diabetes duration (r = 0.378,
P = 0.002), systolic blood pressure (r = 0.278, P = 0.024),
diastolic blood pressure (r = 0.335, P = 0.006), waist
circumference (r = 0.293, P = 0.017), and waist-to-hip ratio
(r = 0.378, P = 0.001). No signiﬁcant association was found
betweenPWVandgender,BMI,smoking status,HbA1c,and
plasma levels of HDL-C, LDL-C, and triglycerides.
A signiﬁcant negative correlation was observed between
PWV and the E/I index (r =− 0.533, P<0.001; Figure 1)
that was modestly attenuated when adjusting for heart rate
(r =− 0.452, P<0.001). A weaker negative correlation was
observed between PWV and the 30:15 index (r =− 0.275,
P = 0.025), which was vanished after adjusting for heart
rate (r =− 0.137, P = 0.29). No signiﬁcant correlation
was observed between PWV and the Valsalva index as well
as the change in blood pressure after standing up. After
adjustment for age, PWV remained signiﬁcantly correlated
only to diastolic blood pressure (r = 0.296, P = 0.017),
waist-to-hip ratio (r = 0.293, P = 0.018), and E/I index
(r = 0.401, P = 0.001).
In multivariable linear regression analysis, with PWV
as dependent variable, a multivariable model including
the above signiﬁcantly correlated to PWV parameters was
created (Table 4). In this model, age, waist-to-hip ratio, and
E/I index were independently associated with PWV. E/I
index was the strongest predictor of PWV (standardized
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Figure 1:Simplelinearcorrelationbetweenpulsewavevelocityand
E/I index.
β-regression coeﬃcient = −0.326, P = 0.015). E/I index,
age and waist-to-hip ratio accounted for 43.7% of PWV
variability (Table 4).
3.1. Discussion. The main ﬁnding of the present study is that
the compliance of large arteries assessed by measurement of
PWV in patients with T1D, even at a relatively early stage of
the disease, is related to certain indices of parasympathetic
autonomic nervous system function, principally the beat-to-
beat variation in heart rate with respiration.
The participants of the present study were carefully
selectedinordertoavoidthepotentialeﬀectofdiabeticcom-
plications, both on PWV and autonomic function. Hence,
participants were young (<40 years of age), had no history of
hypertension, and were free of macrovascular complications
and nephropathy, including microalbuminuria. In addition,
allpatientsweretreatedwithintensiveinsulintherapy(either
multiple daily injections or continuous subcutaneous insulin
infusion), having a fairly decent glycemic control (mean
HbA1c: 7.4%). It is known that renal disease, even in the
microalbuminuric stage, is related to elevation of blood
pressure, decreased blood pressure decline during sleep,
increased arterial stiﬀness, and impaired autonomic nervous
system function [29–31]. Hence, the exclusion of patients
with any degree of diabetic nephropathy was important
in order to eliminate any potential confounding eﬀect of
nephropathy on either arterial compliance or autonomic
function.
According to our results, PWV correlated negatively to
the E/I index (r =− 0.533) and (to a lower extent) the 30:15
ratio (r =− 0.275) but not to the VM index (r =− 0.119).
After adjustment for heart rate at rest, the association of E/I
index and PWV remained signiﬁcant (r =− 0.452, P<
0.001), while the 30:15 ratio was not related signiﬁcantly
to PWV. After full adjustment for possible confounding
factors, the association between E/I index and PWV not
only remained signiﬁcant (Table 4), but E/I index was the
strongest predictor of PWV in the model.4 Experimental Diabetes Research
Table 3: Mean (SD) PWV value in patients with normal, borderline, and abnormal autonomic nervous function tests. Total score is
considered normal when ≤1, borderline when 2-3, and abnormal when ≥4.
Normal result Borderline result Abnormal result P for trend
PWV (m/sec)
Deep breathing test (E/I index) 5.37 5.53 6.19∗∗ 0.006
Orthostatic test (30:15 ratio) 5.46 6.38∗ 5.96 0.038
Valsalva test (VM index) 5.52 5.36 5.48 0.89
Orthostatic test (BP change) 5.55 5.68 6.43 0.27
Total score 5.47 5.58 6.35∗ 0.042
∗P<0.05, ∗∗P<0.01, for comparisons of PWV values between abnormal/borderline test and normal test (adjusted for multiple comparisons using
Bonferroni adjustments).
Table 4: Multivariable linear regression model with pulse wave
velocity set as dependent variable. Additional variables included in
the model (and turned to be nonsigniﬁcant) were gender, duration
of diabetes, and diastolic blood pressure.
Variable β-coeﬃcient Standardized
β-coeﬃcient P 95% CI
(for β)
Age 0.048 0.317 0.005 0.016, 0.081
Waist-hip
ratio 2.625 0.218 0.033 0.216, 5.033
E/I index −1.930 −0.326 0.002
−3.110,
−0.750
R2 = 0.437.
The deep breathing test (expressed by the E/I index) is
considered as the most reproducible of the cardiac auto-
nomic function tests [32]. Interestingly, further analysis of
the data showed that the VM index was aﬀected by smoking
status, being signiﬁcantly lower in smokers. In addition,
smoking status aﬀected the relation between VM index and
PWV, being of borderline signiﬁcance in nonsmokers (r =
−0.288, P = 0.07) but neutral in smokers. It has been
previously reported that smoking may attenuate the Valsalva
heart rate response, due to dysfunction in some part of the
autonomic reﬂex arch [33].
Both the deep breathing test and the standing-up test (as
it concerns heart rate variation), reﬂect mainly parasympa-
thetic activity of the heart innervation (although the sym-
pathetic nervous system may partly aﬀect these measures)
[34, 35]. On the other hand, heart rate variation during the
Valsalvamaneuverismediatedthroughalternatingactivation
of parasympathetic and sympathetic nerve ﬁbres [35].
Previous cross-sectional studies have demonstrated an
association between arterial stiﬀness and autonomic neu-
ropathy in both types of diabetes (type 1 and type 2) [19–
22, 36]. In the study by Ahlgren et al., a signiﬁcant correla-
tion between E/I index and aortic distensibility (measured
noninvasively by ultrasound) was found in females (but not
in males) with type 1 diabetes [20]. Patients with established
nephropathy (both macro- and microalbuminuria) were
included. In the present study, the association between PWV
and autonomic function indices was gender independent. It
has to be noted, however, that due to the small population
size, we were not able to perform gender-speciﬁc analysis,
and a potential gender eﬀect might have been missed.
In a subsequent Dutch study by van Ittersum et al.
[22], performed in a cohort very similar to our population
(patientswithT1Dwithoutmicroalbuminuria),itwasfound
that large artery compliance was related to the shortening
of the RR interval of the ECG after standing up, but not to
the heart rate variation during respiration. On the contrary,
in our cohort, a strong negative correlation of large arterial
stiﬀness to the heart rate variation during respiration was
observed. On the other hand, we also found a (negative)
correlation of PWV to the RR shortening after standing
up, but this was weak and disappeared after adjustment for
resting heart rate. Some diﬀerences between the two studies
might explain this discrepancy: ﬁrst (1), in the Dutch study,
heart rate variation during respiration was expressed as the
maximal diﬀerence in duration of the RR interval of the ECG
during deep inspiration and expiration while in the present
study the same parameter was expressed as the ratio between
the two respective values; second (2), Van Ittersum et al.
performed adjustment for 24-hour heart rate while we only
had one measurement of resting heart rate available; third
(3), the demographic and clinical characteristics of patients
included in the present study were suggestive of an even
“earlier”T1DpopulationthaninthestudybyvanIttersumet
al. Indeed, our cohort was younger (27.1±6v e r s u s3 2 .6±11
years) and had a shorter duration of diabetes (12.3 ± 7.7
versus 14.6 ± 10 years). In addition, patients in our study
had better glucose control than in the Dutch study (HbA1c:
7.4±4.5v e r s u s8 .1±1.4). As a consequence, the mean PWV
values of the two populations was diﬀerent, with a (close to
normal) 5.6 ± 0.9m/s in our study, compared to a clearly
higher value of 6.5 ± 1.8m/s in the study by van Ittersum
et al. It can be assumed that the presence of a less advanced
disease in our population may have allowed the association
betweenparasympatheticactivity(expressedastheE/I ratio)
and arterial stiﬀness to emerge.
The association between PWV and cardiac autonomic
function has been previously examined in a small study in
healthy individuals as well [37]. Similarly to our results,
moderate correlations were found between autonomic
indices expressing mainly parasympathetic activity and
PWV. Healthy volunteers participating in that study, were
older than our cohort (mean age 38.2 ±11.2y e a r s ) .
Both the decrease of large arteries elasticity and the
dysfunction of autonomic nervous system appear early in
the natural history of T1D [7–9]. The question arising from
the present (and the previously mentioned) study is whichExperimental Diabetes Research 5
of the events (autonomic dysfunction and stiﬀness of the
large arteries) appear ﬁrst and whether there is a causative
relationship between each other. Two reasonable hypotheses
may be generated: arterial stiﬀness may produce dysfunction
of the cardiac autonomic nervous system or (the other way
round) CAN may induce stiﬀness of the large arteries. Of
course, a noncausal relation may also be the case, since the
two conditions may develop in parallel as consequences of
ageing and accelerated because of the “toxic” hyperglycemic
environment.Inthepresentstudy,HbA1cwasnotassociated
with PWV (r = 0.072, P = 0.59). It might be hypothesized,
however, that a single measurement of HbA1c, undertaken
some years after the initiation of diabetes, might not reﬂect
the overall glycemic burden, acquired during the entire
course of the disease.
A possible mechanism that might explain the ﬁrst
hypothesis is the impairment of baroreceptor function,
induced by stiﬀening of the arterial wall [38]. On the other
hand, dysfunction of the cardiovascular autonomic system
mayinﬂuencetheelasticityofthearterialwallbyaﬀectingthe
vascular tone of large arteries. In animal studies, it has been
shown that the integrity of the autonomic nervous system
is important in the preservation of the elastic properties
of the aorta [39–42]. Most of the animal studies, however,
implicated an acute modulation of the autonomic nervous
systemwhereas,inpatientswithT1D,achronic,gradual,and
cumulative eﬀect is present. Another mechanism possibly
implicated in the induction of arterial stiﬀness by autonomic
dysfunction is the increase in heart rate. Indeed, increases in
heart rate per se result in stiﬀening of arteries independently
of changes in activity of the autonomic nervous system [39,
43]. In the present analysis, the correlation between the E/I
index and PWV remained highly signiﬁcant after adjustment
for heart rate, a ﬁnding indicating that the association
between parasympathetic dysfunction and arterial stiﬀness is
not mediated by an increase in heart rate. Finally, alterations
in autonomic tone may lead to artery stiﬀening through
trophicinﬂuence,leadingtochangingthestructureofvessels
[44, 45].
In the Pittsburgh Epidemiology of Diabetes Complica-
tions(EDC)study,ithasbeenshownprospectivelythatCAN
(expressed as the E/I ratio) is associated with increased arte-
rial stiﬀness measures, 18 years later in life of patients with
childhood-diagnosed T1D [46]. The authors of that study
concluded that CAN may exert a major pathophysiological
role in the development of arterial stiﬀening in patients with
T1D. The main limitation of the present study is its cross-
sectional design and the small population size. However, the
latter, is partly overcome by the homogeneous characteristics
of the patients, being of a young age, relatively short disease
duration, decent glycemic control, and, most importantly,
free of macrovascular and renal complications of diabetes.
4. Conclusions
According to the results of the present study, cardiac auto-
nomic function, particularly parasympathetic activity of the
heart, as expressed by heart rate variation during respiration,
correlates strongly to large arterial stiﬀness in patients with
type 1 diabetes. Most interestingly, this ﬁnding was observed
in a population of young patients, without history of
hypertension, with relatively short disease duration and free
of macrovascular and/or renal complications. A prospective
followup of these patients might provide further informa-
tion regarding the progression of both cardiac autonomic
function (including the development of cardiac autonomic
neuropathy) and arterial stiﬀness.
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